Month: October 2019

SunGen Pharma Receives Eighth ANDA Approval from US FDA

PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its eighth ANDA approval from the US Food and Drug …

Bombardier Reports Third Quarter 2019 Results

  • Consolidated revenues of $3.7 billion, representing 8% organic growth(1)
  • Consolidated adjusted EBITDA(2) and adjusted EBIT(2) of $255 million and $159 million, respectively; $143 million of reported EBIT
  • Free cash flow usage(2) of $682 million, supporting Global

Ingredion Incorporated Reports Third Quarter 2019 Results

  • Third quarter 2019 reported and adjusted EPS* were $1.47 and $1.82, respectively, compared with $1.32 and $1.70 in the third quarter 2018, respectively
  • Year-to-date 2019 reported and adjusted EPS were $4.51 and $5.03, respectively, down from $4.80 of reported EPS

Sanofi Q3 well on track

Paris, October 31, 2019

Sanofi Q3 well on track

  Q3 2019 Change Change
at CER
9M 2019 Change Change
at CER
IFRS net sales reported €9,499m +1.1% -1.1% €26,518m +4.1% +2.2%
IFRS net income reported €1,766m -22.3% €2,816m -30.5%